#Cannabis Stock News:
Alliance Growers (CSE: $ACG) Announces Extension with BRIM For MJ Botany
Centres
December 16, 2016 (Investorideas.com Newswire)
Alliance Growers (CSE: ACG)and Botanical Research In Motion International Inc.
(BRIM) have agreed to extend the period of time required to finalize the
definitive licence agreement.
Alliance is finalizing a Definitive License
Agreement with B.R.I.M. for a Canada Exclusive License to jointly develop and
operate cannabis Botany Centres. The initial project is planned as a staged
development of a 40,000 square foot facility being located near Vancouver,
B.C., to be the first of its kind in Western Canada to house a DNA Botany lab,
extraction facility and Tissue Culture Plantlet Production facility to service
the cannabis market and agriculture market in general. The planned facility
will grow cannabis plantlets using proprietary tissue culture propagation,
specifically the “Chibafreen Invitro Plant Production System”, which assures
consistent composition and purity.
The development of the cannabis botany centre,
together with partnerships and investments, is designed to provide Alliance
Growers with the following:
·
Produce revenue from the sale of cannabis and other
plantlets under contract;
·
Generate revenue from the processing and resale of
cannabidiol (CBD) oil in Canada, the United States and offshore;
·
Providing cold-storage facilities utilizing the
one-of-a-kind cryo-tissue cold-storage technology for tissue culture
preservation and regeneration as needed on a long-term basis;
·
Provide extraction services as retail services for
cultivators and create custom profiles for extraction for botanicals oils for
retail market.
First strategic investment in a private medical
cannabis company
Through a serious of strategic partnerships and
investments under negotiation with licensed producers at various stages in the
licence process, Alliance Growers is focused on securing long-term plantlet
sale contracts for the cannabis botany centre and off-take agreements at
wholesale costs for flowers to be acquired by Alliance Growers for CBD oil
extraction.
Alliance Growers has negotiated terms on a
10-per-cent non-dilutive interest in a private company in Ontario that has
assembled a top-tier growing team with management that has the expertise to
expedite the licensed producer application process.
Joint venture with Israeli medical cannabis company
Further to the company's commitment to become a
leading supplier of pharmaceutical-grade CBD oil on a global basis, Alliance
Growers continues discussions setting out terms with an Israeli medical
cannabis company.
Included in the discussions is the joint
development of 50 hectares of land for the growth of high-quality cannabis
plants, as legally permitted in an offshore, low-operating-cost jurisdiction.
This would facilitate the importation of the CBD oil into various states in the
United States, into Canada when legalized and into other countries as
permitted.
This joint venture and other similar partnerships
are what will make Alliance Growers stand out from other Canadian cannabis
companies that are directly affected by Health Canada rules and regulations.
Alliance Growers plans to produce and sell more CBD oil from outside Canada.
The Hemp Business Journal reports that the CBD
market in the United States is growing at a rate of 30 per cent per year and
forecasts that sales of CBD oils from marijuana-based sources are expected to
reach $1.65-billion, or 79 per cent of the total CBD market of $2.1-billion, by
2020.
As previously announced, Alliance Growers is
undertaking a private placement of up to 10 million units at a price of 20
cents per unit, for gross proceeds of up to $2-million. Each unit comprises one
common share and one share purchase warrant. Each share purchase warrant will
entitle the holder to acquire one additional common share in the capital of the
company at a price of 30 cents per share, for a period of two years from the
date the units are issued. A portion of the proceeds may be used for
finalization of the company's current projected arrangements.
About Alliance Growers
Alliance Growers is a diversified cannabis company
driven by the company's four-pillar organization plan: MMPR (marihuana for
medical purposes regulations) cannabis production facilities, distribution
network, consumer products, and research and development.
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED
AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS
RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking
statements and forward-looking information within the meaning of applicable
securities laws. These statements relate to future events or future performance.
All statements other than statements of historical fact may be forward-looking
statements or information. More particularly and without limitation, the news
release contains forward-looking statements and information relating to the use
of proceeds of the Financing, as well as the Company’s corporate strategy. The
forward-looking statements and information are based on certain key
expectations and assumptions made by management of the Company, including,
without limitation, the Company’s ability to carry out its business plan
following the issuance of the required licenses by Health Canada. Although
management of the Company believes that the expectations and assumptions on
which such forward-looking statements and information are based are reasonable,
undue reliance should not be placed on the forward-looking statements and
information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are
provided for the purpose of providing information about the current
expectations and plans of management of the Company relating to the future.
Readers are cautioned that reliance on such statements and information may not
be appropriate for other purposes, such as making investment decisions. Since
forward-looking statements and information address future events and
conditions, by their very nature they involve risks and uncertainties. Actual
results could differ materially from those currently anticipated due to a
number of factors and risks. These include, but are not limited to, the
Company’s ability to identify and complete additional suitable acquisitions to
further the Company’s growth as well as risks associated with the medical
marijuana industry in general, such as operational risks in development and
production delays or changes in plans with respect to development projects or
capital expenditures; the uncertainty of the capital markets; the uncertainty
of receiving the required licenses, production, costs and expenses; health,
safety and environmental risks; marketing and transportation; loss of markets;
environmental risks; competition; incorrect assessment of the value of the
potential market; ability to access sufficient capital from internal and
external sources; failure to obtain required regulatory and other approvals and
changes in legislation, including but not limited to tax laws and regulated
regulations. Accordingly, readers should not place undue reliance on the
forward-looking statements, timelines and information contained in this news
release. Readers are cautioned that the foregoing list of factors is not
exhaustive.
The forward-looking statements and information
contained in this news release are made as of the date hereof and no
undertaking is given to update publicly or revise any forward-looking
statements or information, whether as a result of new information, future
events or otherwise, unless so required by applicable securities laws or the
Canadian Securities Exchange. The forward-looking statements or information
contained in this news release are expressly qualified by this cautionary
statement.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
The following is a paid for news release on Investorideas.com
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment